## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no methods, results, figures, or tables were provided
- **Shared manuscript claim summary** The authors propose CLARA, a hierarchical two-stage learning framework for node classification in graph-structured data under class imbalance. The method first applies a coarse subgraph-level classifier to select regions likely to contain minority instances, then a fine-grained node-level predictor within those regions. The authors claim substantial improvements over established imbalance-handling methods on benchmark graph datasets, with an F1-score of 88.3%, and report significant gains in protein–ligand binding site prediction.
- **Visible evidence base** Abstract text only; no quantitative comparisons, dataset descriptions, baseline specifications, or statistical details are available
- **Missing materials affecting confidence** Full manuscript, methods section, experimental setup, dataset details, baseline implementations, hyperparameter choices, ablation studies, code availability, and all figures and tables

## Reviewer
- **Overall assessment** The abstract presents a conceptually interesting hierarchical approach to a well-recognized problem in graph learning. The two-stage design is plausible and potentially valuable. However, the evidence provided in the abstract is insufficient to evaluate the validity, robustness, or generalizability of the claims. Key experimental details, baseline comparisons, and statistical rigor are absent. The biological application is mentioned but not substantiated with any specific metrics or context. The work may have merit, but the current submission does not allow for a meaningful assessment of its technical soundness or scientific impact.
- **Who would be interested in the results, and why** Researchers working on graph neural networks, particularly those addressing class imbalance in node classification tasks, would find the hierarchical framework relevant. Computational biologists and structural bioinformaticians interested in protein function prediction, including binding site identification, may also be interested given the reported application. The general approach of coarse-to-fine learning could appeal to a broader machine learning audience working on scalable and selective prediction in large graphs.
- **Major strengths** The problem addressed is important and timely, as class imbalance in graph-structured data is a recognized limitation of GNNs. The proposed two-stage hierarchical design is conceptually clear and offers a plausible mechanism for improving sensitivity while maintaining scalability. The inclusion of a biological application domain adds potential interdisciplinary relevance.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3, R1-M4
- **Assessment against Nature-style criteria**  
  Originality: The hierarchical two-stage idea is not entirely novel in the broader machine learning literature, but its specific application to graph node classification under imbalance may offer a fresh angle. However, without a detailed comparison to existing hierarchical or coarse-to-fine methods, the degree of novelty cannot be established.  
  Scientific importance: The problem is significant, and a robust solution would be valuable. The potential biological application adds importance, but the current evidence does not demonstrate a meaningful advance.  
  Interdisciplinary readership: The abstract bridges graph learning and structural biology, which could attract readers from both communities. However, the biological claims are unsubstantiated in the abstract.  
  Technical soundness: Cannot be assessed from the abstract alone. No methodological details, experimental protocols, or statistical analyses are provided.  
  Readability for nonspecialists: The abstract is clearly written and accessible, with the two-stage concept explained in understandable terms. However, the lack of context for the biological application and the absence of any quantitative framing limit its accessibility to nonspecialists.
- **Recommendation posture** Currently not established from the provided evidence. The conceptual direction is promising, but the abstract alone does not provide sufficient support for the core claims. A full manuscript with detailed methods, comprehensive experiments, and rigorous statistical analysis would be required to assess whether the case can be made.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The authors claim "substantial gains over established imbalance-handling methods" and report an F1-score of 88.3%.  
- **Evidence pointer** Abstract; location not provided  
- **Concern** The abstract provides no comparative data, no baseline names, no dataset descriptions, and no context for the reported F1-score. It is impossible to determine whether 88.3% represents a meaningful improvement, what task it corresponds to, or how it compares to prior work.  
- **Why it matters** The central claim of the paper rests on the demonstrated superiority of CLARA over existing methods. Without any quantitative comparison or experimental context, the claim is unsupported and cannot be evaluated.  
- **Resolution test** Provide a full experimental section with dataset characteristics, baseline implementations, performance tables, and statistical significance tests. The F1-score must be contextualized with respect to specific tasks, datasets, and competing methods.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Methodological detail  
- **Claim pointer** The authors describe a two-stage framework with a coarse subgraph-level classifier followed by a fine-grained node-level predictor.  
- **Evidence pointer** Abstract; location not provided  
- **Concern** No details are given on how subgraphs are defined, how the coarse classifier is trained, how regions are selected, how the fine-grained predictor operates, or how the two stages are integrated. The architecture, loss functions, and training procedures are entirely unspecified.  
- **Why it matters** The proposed method cannot be reproduced, validated, or compared to alternatives without a clear description of the algorithmic design. The scientific contribution depends on the technical implementation being both sound and transparent.  
- **Resolution test** Provide a detailed methods section describing the subgraph construction, model architectures, training objectives, hyperparameter choices, and the mechanism for region selection and node-level prediction.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Biological claim substantiation  
- **Claim pointer** The authors state that "the same strategy achieves significant improvements in protein–ligand binding site prediction."  
- **Evidence pointer** Abstract; location not provided  
- **Concern** No specific results, metrics, datasets, or comparisons are provided for the protein–ligand binding site prediction task. The term "significant" is used without any statistical support.  
- **Why it matters** The biological application is a key part of the claimed interdisciplinary impact. Without quantitative evidence, the claim of effectiveness in this domain is unsubstantiated and may mislead readers in the structural biology community.  
- **Resolution test** Provide a dedicated section on the binding site prediction experiments, including dataset details, evaluation metrics, baseline comparisons, and statistical significance testing.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Generalizability and robustness  
- **Claim pointer** The authors claim "broad and consistent effectiveness across both biological and general graph learning tasks."  
- **Evidence pointer** Abstract; location not provided  
- **Concern** The abstract mentions "benchmark graph datasets" without specifying which ones, how many, or what types of imbalance were tested. No ablation studies, sensitivity analyses, or failure cases are reported.  
- **Why it matters** The claim of broad effectiveness requires evidence across diverse graph types, imbalance ratios, and task configurations. Without this, the generalizability of the method remains an assertion rather than a demonstrated property.  
- **Resolution test** Include experiments on multiple benchmark datasets with varying imbalance levels, report performance across different minority class proportions, and provide ablation studies to isolate the contribution of each stage.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Abstract wording  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The phrase "structurally marginalized within the graph" is vague and not defined. It is unclear whether this refers to low degree, peripheral position, or some other structural property.  
- **Required correction** Define the term explicitly or rephrase to describe the specific structural characteristics of minority nodes that motivate the hierarchical approach.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Reproducibility  
- **Affected element** Resource availability  
- **Evidence pointer** Abstract; location not provided  
- **Issue** No mention is made of code or data availability, which is important for reproducibility in the machine learning community.  
- **Required correction** State whether code and datasets will be made publicly available, and if so, under what license and at what repository.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Terminology  
- **Affected element** Method name and framing  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The acronym CLARA is introduced without explanation. It is unclear what it stands for or whether it relates to any existing method with a similar name.  
- **Required correction** Expand the acronym at first use and clarify any potential confusion with prior work.

## Risk / unsupported claims
- The claim of "substantial gains over established imbalance-handling methods" is unsupported due to the absence of any comparative data.
- The reported F1-score of 88.3% is uncontextualized and cannot be interpreted without task and dataset details.
- The claim of "significant improvements in protein–ligand binding site prediction" is unsupported by any quantitative evidence.
- The claim of "broad and consistent effectiveness" across tasks is not assessable without a description of the datasets and experimental scope.
- The overall effectiveness of the proposed hierarchical framework cannot be evaluated from the abstract alone.